These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 23094127)

  • 21. Pelvic exenteration for recurrent or persistent cervical cancer: experience of five years at the National Cancer Institute in Mexico.
    Terán-Porcayo MA; Zeichner-Gancz I; del-Castillo RA; Beltrán-Ortega A; Solorza-Luna G
    Med Oncol; 2006; 23(2):219-23. PubMed ID: 16720922
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pelvic exenteration and sacral resection for locally advanced primary and recurrent rectal cancer.
    Yamada K; Ishizawa T; Niwa K; Chuman Y; Aikou T
    Dis Colon Rectum; 2002 Aug; 45(8):1078-84. PubMed ID: 12195193
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Does intra-operative radiation at the time of pelvic exenteration improve survival for patients with recurrent, previously irradiated cervical, vaginal, or vulvar cancer?
    Backes FJ; Billingsley CC; Martin DD; Tierney BJ; Eisenhauer EL; Cohn DE; O'Malley DM; Salani R; Copeland LJ; Fowler JM
    Gynecol Oncol; 2014 Oct; 135(1):95-9. PubMed ID: 25084510
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pelvic exenteration for gynecologic malignancies: Postoperative complications and oncologic outcomes.
    Romeo A; Gonzalez MI; Jaunarena J; Zubieta ME; Favre G; Tejerizo JC
    Actas Urol Esp (Engl Ed); 2018 Mar; 42(2):121-125. PubMed ID: 28911880
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Is a Vaginectomy Enough or is a Pelvic Exenteration Always Required for Surgical Treatment of Recurrent Cervical Cancer? A Propensity-Matched Study.
    Vizzielli G; Tortorella L; Conte C; Chiantera V; Gallotta V; Foschi N; Arcieri M; Ferrandina G; Fagotti A; Zattoni F; Scambia G; Ercoli A
    Ann Surg Oncol; 2021 Jun; 28(6):3281-3290. PubMed ID: 33063258
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Survival After Pelvic Exenteration for Cervical Cancer.
    Bouraoui I; Bouaziz H; Tounsi N; Ben Romdhane R; Hechiche M; Slimane M; Rahal K
    J Obstet Gynaecol India; 2022 Feb; 72(1):66-71. PubMed ID: 35125740
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pelvic exenteration combined with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for advanced primary or recurrent colorectal cancer with peritoneal metastases.
    Brown KGM; Ansari N; Solomon MJ; Austin KKS; Hamilton AER; Young CJ
    Colorectal Dis; 2021 Jan; 23(1):186-191. PubMed ID: 32978813
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pelvic exenteration in gynecologic oncology: a single institution study over 20 years.
    Benn T; Brooks RA; Zhang Q; Powell MA; Thaker PH; Mutch DG; Zighelboim I
    Gynecol Oncol; 2011 Jul; 122(1):14-8. PubMed ID: 21444105
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pelvic exenteration for colorectal cancer: oncologic outcome in 59 patients at a single institution.
    López-Basave HN; Morales-Vásquez F; Herrera-Gómez A; Rosciano AP; Meneses-García A; Ruiz-Molina JM
    Cancer Manag Res; 2012; 4():351-6. PubMed ID: 23091398
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pelvic exenteration and composite sacral resection in the surgical treatment of locally recurrent rectal cancer.
    Gawad W; Khafagy M; Gamil M; Fakhr I; Negm M; Mokhtar N; Lotayef M; Mansour O
    J Egypt Natl Canc Inst; 2014 Sep; 26(3):167-73. PubMed ID: 25150132
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Efficacy analysis of neoadjuvant chemoradiotherapy combined with total pelvic exenteration in the treatment of primary T4b rectal cancer].
    Wu T; Wen L; Zhang J; Wu Y; Jiang Y; Chen G; Wang X; Huang S; Wan Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Jan; 22(1):59-65. PubMed ID: 30703795
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
    Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Critical evaluation of contemporary management in a new Pelvic Exenteration Unit: The first 25 consecutive cases.
    Chew MH; Yeh YT; Toh EL; Sumarli SA; Chew GK; Lee LS; Tan MH; Hennedige TP; Ng SY; Lee SK; Chong TT; Abdullah HR; Goh TLH; Rasheed MZ; Tan KC; Tang CL
    World J Gastrointest Oncol; 2017 May; 9(5):218-227. PubMed ID: 28567186
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sacral resection with pelvic exenteration for advanced primary and recurrent pelvic cancer: a single-institution experience of 100 sacrectomies.
    Milne T; Solomon MJ; Lee P; Young JM; Stalley P; Harrison JD; Austin KK
    Dis Colon Rectum; 2014 Oct; 57(10):1153-61. PubMed ID: 25203370
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pelvic exenteration with rectal resection for different types of malignancies at two tertiary referral centres.
    Garcia-Granero A; Biondo S; Espin-Basany E; González-Castillo A; Valverde S; Trenti L; Gil-Moreno A; Kreisler E
    Cir Esp (Engl Ed); 2018 Mar; 96(3):138-148. PubMed ID: 29229359
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic Impact of Intra-abdominal/Pelvic Inflammation After Radical Surgery for Locally Recurrent Rectal Cancer.
    Tanaka M; Kanemitsu Y; Shida D; Ochiai H; Tsukamoto S; Nagino M; Moriya Y
    Dis Colon Rectum; 2017 Aug; 60(8):827-836. PubMed ID: 28682968
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Predictors for long-term survival after interdisciplinary salvage surgery for advanced or recurrent gynecologic cancers.
    Fleisch MC; Pantke P; Beckmann MW; Schnuerch HG; Ackermann R; Grimm MO; Bender HG; Dall P
    J Surg Oncol; 2007 May; 95(6):476-84. PubMed ID: 17192947
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pelvic exenteration for men with locally advanced rectal cancer: a morbidity analysis of complicated cases.
    Hsu TW; Chiang FF; Chen MC; Wang HM
    Asian J Surg; 2011 Jul; 34(3):115-20. PubMed ID: 22208686
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Urological outcomes following pelvic exenteration for non-urological malignancies.
    Lazarovich A; Drori T; Guttman Y; Rosenzweig B; Ben-Yaaqov A; Korach J; Nissan A; Dotan ZA
    Heliyon; 2024 Apr; 10(8):e29640. PubMed ID: 38644885
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Urinary diversion after total pelvic exenteration for rectal cancer.
    Russo P; Ravindran B; Katz J; Paty P; Guillem J; Cohen AM
    Ann Surg Oncol; 1999 Dec; 6(8):732-8. PubMed ID: 10622500
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.